Stocks To Watch Today: Hindustan Zinc, Biocon, DMart, Hero MotoCorp, Bank of Maharashtra, MOIL

Capital Small Finance Bank, V2 Retail and V-Mart Retail are some of the other stocks that will be on the radar on Friday.

featured-image

Hindustan Zinc Ltd., Avenue Supermarts Ltd., Bank of Maharashtra and Biocon Ltd.

are some of the stocks that will be in focus on Friday trade. Hero MotoCorp, Capital Small Finance Bank Ltd., MOIL Ltd.



, V-Mart Retail Ltd. and V2 Retail Ltd. released their quarterly business updates for the October-December period.

KPI Green Energy Ltd. and Garware Technical Fibres Ltd. will go ex-trade for their bonus issues.

Hindustan Zinc: The company reported a 2% year-on-year decline in mined metal production to 265 kilotonnes for the third quarter of fiscal 2025. Capital Small Finance Bank: The small finance bank in its third quarter business update reported total deposits of Rs 8,384 crore up 12.2% year-on-year.

Bank of Maharashtra: The bank's gross advances rose 21.19% on a yearly basis to Rs 2.29 lakh crore in the October-December quarter.

Avenue Supermarts: The company's standalone revenue from operations rose 17.5% year-on-year at Rs 15,565 crore in the quarter ended December. MOIL: The company achieved best-ever third quarter in terms of performance.

It reported production of manganese ore of 4.6 lakh tonnes, while the sales rose 13% to 3.88 lakh tonnes.

Hero MotoCorp: The company's total sales in December fell by 17.5% to 3.24 lakh units and the domestic sales was down 22% at 2.

94 lakh units. Biocon: The company’s arm Biocon Pharma received approval for the Tacrolimus capsule from National Medical Products Administration, China. Tacrolimus is an immunosuppressant used in the treatment of organ transplant patients, which reduces the body’s ability to reject a transplanted organ.

V2 Retail: The company reported 58% jump in standalone revenue from operations to Rs 591 crore in the third quarter of this fiscal. It has achieved same store sales growth of 25%. V-Mart Retail: The company reported revenue from operations at Rs 1,027 crore, up 16% in the third quarter of financial year 2024.

It has achieved same store sales growth of 10% in the previous quarter. Wockhardt: Indian drug regulator approved Wockhardt's new generation oral antibiotic Miqnaf for the treatment of community-acquired bacterial pneumonia. KPI Green Energy: The stock will ex-trade for 1:2 bonus issue.

Garware Technical Fibres: The stock will ex-trade for 4:1 bonus issue..